FDA Warning Letter — Maverik 417
The FDA took a Warning Letter action against Maverik 417 on Aug 30, 2018 (Clifton, CO). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- Maverik 417
- Date
- Aug 30, 2018
- Fiscal Year
- 2018
- Product Type
- Tobacco
- Center
- CTP
- Location
- Clifton, CO (United States)